SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-24-005332
Filing Date
2024-02-07
Accepted
2024-02-07 18:55:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13ga.htm SC 13G/A 91237
  Complete submission text file 0001493152-24-005332.txt   92532
Mailing Address 101 EAST 52ND ST NEW YORK NY 10022
Business Address
HIRSCHMAN ORIN (Filed by) CIK: 0001131362 (see all company filings)

Type: SC 13G/A

Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2
Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555
Medicenna Therapeutics Corp. (Subject) CIK: 0001807983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-92189 | Film No.: 24606304
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)